NOS1 and osteosarcoma: The molecular mechanism of 2-ME still remains unclear; however, Gorska et al. demonstrated that 2-ME enhanced the nuclear fraction of neuronal nitric oxide synthase (nNOS) in a pediatric osteosarcoma cell type (143b) [19,20], resulting in the release of nitric oxide (NO) molecules.